Samuel N. Hazen - 31 Jan 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
CEO, Director
Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
31 Jan 2024
Transactions value $
$0
Form type
4
Filing time
02 Feb 2024, 18:43:46
Previous filing
08 May 2023
Next filing
21 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Award $0 +79.8K $0.00 79.8K 31 Jan 2024 Common Stock 79.8K $304.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.